An event that’s slated to be held at IMET later this month is set to provide a window into how investors think about early-stage life sciences companies.
1st Pitch Life Science, which is being organized by New York–based Mid Atlantic Bio Angels provides a look at what happens when an investor group meets after hearing a pitch.
The Oct. 24 event features pitches from entrepreneurs. The group targets founders who want to get some practice on their pitch. The event also offers “a chance to hear what happens in those closed-door discussions, and to learn what really matters to investors,” according to the event description.
The audience also gets to weigh in, voting on a “Best in Show” winner.
The event is set to be held from 5-8 p.m. It’s preceded by a roundtable for academics and entrepreneurs which requires separate registration.